Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
Department of Stem Cells & Developmental Biology at Cell Science Research Center, Royan Institute for Stem Cell Biology & Technology, ACECR, Tehran, Iran.
J Cell Mol Med. 2019 Apr;23(4):2442-2456. doi: 10.1111/jcmm.14090. Epub 2019 Feb 1.
Several evidences support the idea that a small population of tumour cells representing self-renewal potential are involved in initiation, maintenance, metastasis, and outcomes of cancer therapy. Elucidation of microRNAs/genes regulatory networks activated in cancer stem cells (CSCs) is necessary for the identification of new targets for cancer therapy. The aim of the present study was to predict the miRNAs pattern, which can target both metastasis and self-renewal pathways using integration of literature and data mining. For this purpose, mammospheres derived from MCF-7, MDA-MB231, and MDA-MB468 were used as breast CSCs model. They had higher migration, invasion, and colony formation potential, with increasing in stemness- and EMT-related genes expression. Our results determined that miR-204, -200c, -34a, and -10b contemporarily could target both self-renewal and EMT pathways. This core regulatory of miRNAs could increase the survival rate of breast invasive carcinoma via up-regulation of OCT4, SOX2, KLF4, c-MYC, NOTCH1, SNAI1, ZEB1, and CDH2 and down-regulation of CDH1. The majority of those target genes were involved in the regulation of pluripotency, MAPK, WNT, Hedgehog, p53, and transforming growth factor β pathways. Hence, this study provides novel insights for targeting core regulatory of miRNAs in breast CSCs to target both self-renewal and metastasis potential and eradication of breast cancer.
有几项证据支持这样一种观点,即一小部分具有自我更新能力的肿瘤细胞代表着肿瘤的发生、维持、转移和癌症治疗效果。阐明癌症干细胞(CSC)中激活的 microRNA/基因调控网络对于确定癌症治疗的新靶点是必要的。本研究的目的是利用文献整合和数据挖掘来预测能够靶向转移和自我更新途径的 microRNA 模式。为此,我们使用 MCF-7、MDA-MB231 和 MDA-MB468 来源的乳腺球体作为乳腺 CSC 模型。这些球体具有更高的迁移、侵袭和集落形成能力,同时伴随着干细胞和 EMT 相关基因表达的增加。我们的研究结果表明,miR-204、-200c、-34a 和 -10b 可以同时靶向自我更新和 EMT 途径。这些 microRNA 的核心调控因子可以通过上调 OCT4、SOX2、KLF4、c-MYC、NOTCH1、SNAI1、ZEB1 和 CDH2 以及下调 CDH1 来提高乳腺浸润性癌的存活率。这些靶基因大多参与调控多能性、MAPK、WNT、Hedgehog、p53 和转化生长因子β途径。因此,本研究为靶向乳腺 CSC 中的 microRNA 核心调控因子提供了新的见解,以靶向自我更新和转移潜能,并根除乳腺癌。